Preferred Label : Atezolizumab/Bevacizumab Regimen;
NCIt synonyms : Atezolizumab/Bevacizumab; Atezolizumab-Bevacizumab; Atezolizumab-Bevacizumab Regimen; Tecentriq/Avastin;
NCIt related terms : Atezolizumab and Bevacizumab; Atezolizumab and Bevacizumab-onbe; Atezolizumab and Bevacizumab-maly; Atezolizumab and Bevacizumab-awwb; Atezolizumab and Bevacizumab-adcd; Atezolizumab and Bevacizumab-equi; Atezolizumab and Bevacizumab-aybi; Atezolizumab and Bevacizumab-bvzr;
NCIt definition : A regimen consisting of atezolizumab and bevacizumab that can be used in the treatment
of non-small cell lung cancer (NSCLC), mesothelioma and hepatocellular carcinoma (HCC).;
NCI Metathesaurus CUI : CL936978;
Codes from synonyms : 29980; 127412; 127634; 127338; 127560; 127264; 127486; 127190;
Origin ID : C157395;
UMLS CUI : C4763593;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
